Literature DB >> 13686755

Dopamine and basal ganglia diseases.

A BARBEAU.   

Abstract

Entities:  

Keywords:  CATECHOLAMINES/metabolism; GANGLIA, BASAL/diseases; MOVEMENT DISORDERS/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13686755     DOI: 10.1001/archneur.1961.00450070099011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  9 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  [THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

Authors:  W UMBACH; D BAUMANN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

3.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

4.  Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

Authors:  R J Chalmers; R H Johnson; H J Keogh; R N Nanda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

5.  [Phenolic acids and indoles in the urine in Huntington's chorea].

Authors:  W Ruge; H Oepen
Journal:  Humangenetik       Date:  1965

6.  [Biochemical aspects of the effect of L-dopa in patients with Parkinson's disease].

Authors:  E Gründig; F Gerstenbrand; J Oberhummer; M Simanyi; R Schedl; J Weiss
Journal:  Z Neurol       Date:  1972

7.  The effect of L-dopa on postural reflexes in Parkinson's disease.

Authors:  J Chaco; O Abramsky
Journal:  Z Neurol       Date:  1971

8.  Altered growth hormone release in Huntington's chorea.

Authors:  H J Keogh; R H Johnson; R N Nanda; W R Sulaiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-03       Impact factor: 10.154

9.  Computational systems analysis of dopamine metabolism.

Authors:  Zhen Qi; Gary W Miller; Eberhard O Voit
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.